drugset / Trial / NCT01028287

Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN)

NCT01028287 ↗

RandomizedSingle-groupOpen-labelTreatment

Summary

This is a prospective open labeled trial examining the efficacy of ACTHar Gel (porcine ACTH) on the level of proteinuria in patients with diabetic nephropathy and nephrotic range proteinuria.

Timeline

Start
2009-05
Primary completion
2010-12
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator ACTH Unknown 16 iu Subcutaneous
Comparator ACTH Unknown 32 iu Subcutaneous